|
AU1529100A
|
|
Peptide compositions capable of down regulating an antigen specific immune response
|
|
US6423837B1
|
|
Cloning and sequencing of allergens of dermatophagoides house dust mite
|
|
US6982326B1
|
|
Allergenic proteins and peptides from Japanese cedar pollen
|
|
AU7731398A
|
|
Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
|
|
KR20000048780A
|
|
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US5876727A
|
|
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
FI963331A0
|
|
Process for testing a person's sensitivity to household dust mites
|
|
AU5866496A
|
|
Process for cleavage of blocked peptide resins using liquid hydrogen fluoride
|
|
AU5671196A
|
|
Myelin oligodendrocyte glycoprotein peptides and uses thereof
|
|
AU4695296A
|
|
Compositions and methods for treating rheumatoid arthritis
|
|
AU4278296A
|
|
Compositions and treatment for multiple sclerosis
|
|
ZA9509033B
|
|
Composition and treatment for multiple sclerosis
|
|
AU4146796A
|
|
T cell epitopes of the major allergens from ambrosia artemisiifolia
|
|
US6147201A
|
|
Cloning and sequencing of allergens of dermatophagoides (house dust mite)
|
|
US5820862A
|
|
T cell epitopes of the major allergens from dermatophagoides (house dust mite)
|
|
US5840307A
|
|
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
|
|
US5710126A
|
|
T cell epitopes of ryegrass pollen allergen
|
|
ZA9503730B
|
|
Compositions and treatment for multiple sclerosis
|
|
CZ329596A3
|
|
Preparation for treating scattered sclerosis
|
|
US6120769A
|
|
Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
|
